首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   314篇
  免费   22篇
  国内免费   6篇
耳鼻咽喉   1篇
儿科学   9篇
妇产科学   7篇
基础医学   37篇
口腔科学   9篇
临床医学   42篇
内科学   69篇
皮肤病学   1篇
神经病学   14篇
特种医学   45篇
外科学   24篇
综合类   9篇
预防医学   41篇
眼科学   6篇
药学   16篇
肿瘤学   12篇
  2022年   3篇
  2021年   3篇
  2020年   8篇
  2019年   5篇
  2018年   7篇
  2016年   2篇
  2015年   7篇
  2014年   6篇
  2013年   17篇
  2012年   12篇
  2011年   18篇
  2010年   6篇
  2009年   8篇
  2008年   10篇
  2007年   9篇
  2006年   7篇
  2005年   12篇
  2004年   8篇
  2003年   9篇
  2002年   9篇
  2001年   6篇
  2000年   6篇
  1999年   5篇
  1998年   14篇
  1997年   8篇
  1996年   16篇
  1995年   9篇
  1994年   7篇
  1993年   7篇
  1992年   4篇
  1991年   2篇
  1990年   3篇
  1989年   7篇
  1988年   11篇
  1987年   8篇
  1986年   5篇
  1985年   4篇
  1984年   5篇
  1983年   15篇
  1982年   3篇
  1981年   5篇
  1980年   2篇
  1979年   3篇
  1978年   2篇
  1977年   5篇
  1976年   3篇
  1972年   2篇
  1970年   2篇
  1966年   1篇
  1965年   1篇
排序方式: 共有342条查询结果,搜索用时 15 毫秒
1.
Twenty-nine females with metastatic or locally recurrent carcinoma of the breast were treated orally with 1 g of medroxyprogesterone acetate (MPA) daily. This was used as a second- or third-line treatment. Serum concentration of MPA was measured over a 28-day period. We have demonstrated a significantly greater area-under-the-concentration-time curve, peak, and steady-state MPA concentration for Provera at 100- and 200-mg tablets (Upjohn) than for Farlutal at 500-mg tablets (Farmitalia). Relative bioavailability of preparations should be considered when prescribing or assessing treatment results when MPA is used.  相似文献   
2.
3.
Hay  CR; Laurian  Y; Verroust  F; Preston  FE; Kernoff  PB 《Blood》1990,76(5):882-886
Home therapy with porcine factor VIIIC was safe and effective when administered to five hemophilic patients over periods of 8 1/2, 6, 4, 3 1/2, and 2 years. No significant transfusion reactions occurred. Before treatment with porcine factor VIIIC, all five had high-level, high- responding anti-human VIIIC inhibitors initially lacking anti-porcine factor VIIIC activity. Although specific anti-porcine VIIIC inhibitors arose in all patients, these were generally transient, and only one patient became refractory to treatment. We believe that porcine factor VIIIC is the treatment of choice in patients whose inhibitors do not cross-react. All five patients lost their original anti-human VIIIC inhibitors after starting treatment with porcine VIIIC, permitting the reintroduction of human VIIIC in three of them. There has been no recurrence of anti-human VIIIC inhibitor activity during 2 to 3 years of regular treatment with human VIIIC in these patients. This suggests that tolerance to human VIIIC has arisen as a result of treatment with porcine VIIIC. Porcine VIIIC may have a role in the desensitization of some factor VIIIC inhibitor patients.  相似文献   
4.
Cash  FE; Monplaisir  N; Goossens  M; Liebhaber  SA 《Blood》1989,74(2):833-835
Two alpha-globin structural mutants were mapped to their encoding loci by in vitro translation of hybrid-selected alpha 1- and alpha 2-globin mRNA. The more highly expressed mutant, alpha Spanish Town (alpha 27Val), is encoded at the alpha 2 locus and the less expressed mutant, alpha Fort de France (alpha 45Arg), is encoded at the alpha 1 locus. These results further define the distribution of alpha-globin structural mutations within the alpha-globin gene cluster and substantiate the dominant role of the alpha 2-globin locus in alpha- globin expression.  相似文献   
5.
6.
Introduction and ObjectivesThe emergence of SARS-CoV-2, which causes the coronavirus disease (COVID-19) has caused a great impact on healthcare systems worldwide, including hepatitis B and C viruses screening and elimination programs. The high number of COVID-19 hospitalizations represent a great opportunity to screen patients for hepatitis B virus (HBV) and hepatitis C virus (HCV), which was the aim of this study.Material and MethodsCross-sectional, retrospective study performed between April 2020 and 20201 at a referral center in Mexico dedicated to the care of adults with severe/critical COVID-19. We retrieved clinical, demographic, and laboratory results from each patient´s medical records, including antibodies against HCV (anti-HCV), HBV surface antigen (HBsAg), antibodies against the HBV core antigen (anti-HBcAg), and antibodies against HBsAg (anti-HBsAg).ResultsOut of 3620 patients that were admitted to the hospital, 24 (0.66%), 4 (0.11%), and 72 (1.99%) tested positive for anti-HCV, HBsAg, and anti-HBcAg, respectively. Of all seronegative patients, 954 (27%) had undetectable anti-HBsAg and 401 (12%) had anti-HBsAg at protective levels. Blood transfusion was the most relevant risk factor. Only 9.7% of the anti-HBc positive, 25% of the HBsAg positive, and 52% of the anti-HCV positive were aware of their serological status.ConclusionsIn this study we found a prevalence of anti-HCV of 0.66%, HBsAg in 0.11%, and isolated anti-HBcAg in 1.99%. We also found that HBV vaccination coverage has been suboptimal and needs to be reinforced. This study gave us a trustworthy insight of the actual seroprevalence in Mexico, which can help provide feedback to the Hepatitis National Elimination Plan.  相似文献   
7.

Background

The high prevalence of comorbid physical and mental illnesses among veterans is well known. Therefore, ensuring effective communication between primary care (PC) and mental health (MH) clinicians in the Veterans Affairs (VA) health care system is essential. The VA’s Patient Aligned Care Teams (PACT) initiative has further raised awareness of the need for communication between PC and MH. Improving such communication, however, has proven challenging.

Objective

To qualitatively understand barriers to PC-MH communication in an academic community-based clinic by using continuous quality improvement (CQI) tools and then initiate a change strategy.

Design, Participants, and Approach

An interdisciplinary quality improvement (QI) work group composed of 11 on-site PC and MH providers, administrators, and researchers identified communication barriers and facilitators using fishbone diagrams and process flow maps. The work group then verified and provided context for the diagram and flow maps through medical record review (32 patients who received both PC and MH care), interviews (6 stakeholders), and reports from four previously completed focus groups. Based on these findings and a previous systematic review of interventions to improve interspecialty communication, the team initiated plans for improvement.

Key Results

Key communication barriers included lack of effective standardized communication processes, practice style differences, and inadequate PC training in MH. Clinicians often accessed advice or formal consultation based on pre-existing across-discipline personal relationships. The work group identified collocated collaborative care, joint care planning, and joint case conferences as feasible, evidence-based interventions for improving communication.

Conclusions

CQI tools enabled providers to systematically assess local communication barriers and facilitators and engaged stakeholders in developing possible solutions. A locally tailored CQI process focusing on communication helped initiate change strategies and ongoing improvement efforts.
  相似文献   
8.
9.
A prospective study of adolescent pregnancy   总被引:3,自引:0,他引:3  
This study examined prospectively the characteristics contributing to adolescent pregnancy in a pregnant (n=452) and comparison (n=373) group of adolescents. The participants were 15-19-year-old Black and White females in the National Longitudinal Survey of Youth. The variables included race, self-esteem, age-related risks, delinquency history, aspirations and expectations Using regression analyses, adolescent pregnancy in Blacks was predicted by approval of delaying a family and pursuing a career, aspirations of working, and lower educational expectations. Pregnancy in White adolescents was predicted by higher educational wishes, lower educational expectations, desiring more children, and having sex younger. Implications and recommendations are discussed.  相似文献   
10.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号